Rijksinstituut voor Volksgezondheid en Milieu
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study | RIVM
Bron:
rivm.nl